Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,145.50    6.50 (0.57%)
Bid:
1,145.00
Ask:
1,146.00
Spread: 1.00 (0.087%)
Market Cap: £9.72b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Pre Stabilisation Notice

27 May 2026 09:31

RNS Number : 8736F
HSBC Bank plc
27 May 2026
 

27th May 2026

 

Smith & Nephew plc

Pre Stabilisation Notice

HSBC (contact: syndexecution@noexternalmail.hsbc.com) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

Smith & Nephew plc

Guarantor (if any):

n/a

Aggregate nominal amount:

EUR Benchmark

Description:

Fixed rate 12yr due 3rd Jun 2038

Offer price:

TBC

Other offer terms:

Stabilisation:

Stabilising Manager(s):

HSBC Bank plc

Stabilisation period expected to start on:

27th May 2026

Stabilisation period expected to end no later than:

3rd July 2026

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.


[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involved 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAZZGZKRNRGVZG
Date   Source Headline
2nd Mar 20203:46 pmRNSTransaction in Own Shares
2nd Mar 20201:46 pmRNSTotal Voting Rights
25th Feb 20206:20 pmRNSTransaction in Own Shares
24th Feb 20205:52 pmRNSTransaction in Own Shares
24th Feb 202011:12 amRNSDirector/PDMR Shareholding
21st Feb 20204:11 pmRNSDirector/PDMR Shareholding
21st Feb 202010:48 amRNSTransaction in Own Shares
20th Feb 20207:00 amRNSFourth Quarter and Full Year 2019 Results
20th Feb 20207:00 amRNSFourth Quarter and Full Year 2019 Results
7th Feb 20203:10 pmRNSDirector/PDMR Shareholding
6th Feb 20208:24 amRNSDirector Declaration
3rd Feb 20202:25 pmRNSBlock listing Interim Review
3rd Feb 202011:24 amRNSTotal Voting Rights
24th Jan 20207:00 amRNSSmith+Nephew acquires Tusker Medical, Inc.
21st Jan 20203:00 pmRNSNotice of Results
16th Jan 20203:56 pmRNSDirector/PDMR Shareholding
2nd Jan 202010:34 amRNSTotal Voting Rights
2nd Dec 20194:34 pmRNSAdditional Listing
2nd Dec 201912:13 pmRNSTotal Voting Rights
20th Nov 20199:17 amRNSDirector/PDMR Shareholding
14th Nov 20199:17 amRNSDirector/PDMR Shareholding
12th Nov 20194:21 pmRNSTransaction in Own Shares
8th Nov 201912:54 pmRNSTransaction in Own Shares
8th Nov 20199:07 amRNSDirector/PDMR Shareholding
7th Nov 20195:33 pmRNSTransaction in Own Shares
6th Nov 20195:56 pmRNSTransaction in Own Shares
6th Nov 20193:05 pmRNSDirector/PDMR Shareholding
5th Nov 20196:13 pmRNSTransaction in Own Shares
4th Nov 20191:07 pmRNSDirector Declaration
4th Nov 201911:50 amRNSTransaction in Own Shares
1st Nov 20191:24 pmRNSDirector/PDMR Shareholding
1st Nov 201910:53 amRNSTotal Voting Rights
31st Oct 20194:43 pmRNSDirector/PDMR Shareholding
31st Oct 201911:21 amRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSTrading Statement
21st Oct 20197:00 amRNSDirectorate Change
18th Oct 20199:17 amRNSDividend Declaration
15th Oct 20191:14 pmRNSNotification of Major Holdings in Company
14th Oct 20198:56 amRNSNotification of Major Holdings in Company
3rd Oct 201911:15 amRNSNotification of Major Holdings in Company
1st Oct 201910:06 amRNSTotal Voting Rights
30th Sep 20199:30 amRNSNotice of Results
17th Sep 201912:12 pmRNSDirector/PDMR Shareholding
2nd Sep 201910:08 amRNSTotal Voting Rights
23rd Aug 20194:18 pmRNSDirector/PDMR Shareholding
16th Aug 20193:52 pmRNSDirector/PDMR Shareholding
7th Aug 20193:51 pmRNSTransaction in Own Shares
5th Aug 20195:53 pmRNSTransaction in Own Shares
5th Aug 201910:50 amRNSAdditional Listing
2nd Aug 20199:20 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.